✦ LIBER ✦

P-522 A cost minimization analysis of first-line polychemotherapyregimens in the treatment of advanced non-small cell lung cancer

✍ Scribed by Le Lav, K.; Avoinet, S.; Chemali, N.; Vergnenegre, A.; Launois, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CN4 COST MINIMISATION ANALYSIS OF FIRST

✍ R Launois; K Le Lay; L Riou França; S Avoinet; N Chemali; A Vergnenegre 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

PCN34 COST-EFFECTIVENESS OF GEFITINIB FO

✍ PH Liu; FC Hu; JD Wang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Advances in the treatment of second-line

✍ Hanna, N. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 179 KB

CN4 COST-EFFECTIVENESS OF PEMETREXED IN

✍ CG Pinto; M Manaças; LS Miguel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

The clinical evaluation of Iressa first-

✍ Xiuhua Sun; Yang Zhang; Xian Zhang; Jing Yu; Yinghua Li; Xiaoyan Yang; Zhaoxia D 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 76 KB

PCN77 COST-EFFECTIVENESS ANALYSIS OF ERL

✍ TE Ciuleanu; M Dediu; LN Minea; S Baculea; M Szkultecka-Debek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB